This content is from: Features

A guide to further medical use inventions at the EPO

Ylva Skoglösa and Camilla Lidén of Valea discuss the role and meaning of novelty in further medical use applications in Europe

To access our in-house intelligence please request a trial here.

Read this article – and more – for a 30 day period.


Are you already an Managing IP subscriber? Login here

Instant access to all of our content. Membership Options | 30 Day Trial